Evidence map›Paper›PMID 24333293›Full record

ArticleOsteoarthritis and cartilage2014

TSG-6 activity as a novel biomarker of progression in knee osteoarthritis.

H-G Wisniewski, E Colón, V Liublinska, R J Karia, T V Stabler, M Attur, S B Abramson, P A Band, V B Kraus

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Osteoarthritis and cartilage, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 3 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 3 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Soluble biological markers in osteoarthritis.Therapeutic advances in musculoskeletal disease · 2021
    Review
  14. The Inter-α-Trypsin Inhibitor Family: Versatile Molecules in Biology and Pathology.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2020
    Review
  15. Article
  16. Article
  17. The role of indoleamine 2,3 dioxygenase 1 in the osteoarthritis.American journal of translational research · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

H-G WisniewskiDepartment of Microbiology, New York University, School of Medicine, New York, NY 10016, USA. Electronic address: hans-georg.wisniewski@med.nyu.edu.
E ColónDepartment of Microbiology, New York University, School of Medicine, New York, NY 10016, USA.
V LiublinskaDepartment of Statistics, Harvard University, Cambridge, MA 02138, USA.
R J KariaDepartment of Orthopedic Surgery, New York University, School of Medicine, and NYU Hospital for Joint Diseases, New York, NY 10003, USA.
T V StablerDepartment of Medicine, Duke University, School of Medicine, Durham, NC 27710, USA.
M AtturDepartment of Medicine, New York University, School of Medicine, and NYU Hospital for Joint Diseases, New York, NY 10003, USA.
S B AbramsonDepartment of Medicine, New York University, School of Medicine, and NYU Hospital for Joint Diseases, New York, NY 10003, USA.
P A BandDepartment of Orthopedic Surgery, New York University, School of Medicine, and NYU Hospital for Joint Diseases, New York, NY 10003, USA; Department of Biochemistry and Molecular Pharmacology, NYU School of Medicine, New York, NY 10016, USA.
V B KrausDepartment of Medicine, Duke University, School of Medicine, Durham, NC 27710, USA.
New York University Langone Orthopedic Hospital · USDuke University · USNew York University · USHarvard University · US

Funding

Resource Core 3 - Metabolomics CoreP30AG028716 · NIA · DUKE UNIVERSITY · PI Virginia B Kraus · 2006 to 2026
$24.6M
Thermally-Triggered Intra-articular Drug Delivery for OAP01AR050245 · NIAMS · DUKE UNIVERSITY · PI GUILAK, FARSHID · 2003 to 2012
$11.5M
Leukocyte Gene Expression in OsteoarthritisR01AR052873 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ABRAMSON, STEVEN B · 2005 to 2016
$4.8M
STRATEGIES TO PREDICT OSTEOARTHRITIS PROGRESSIONR01AR048769 · NIAMS · DUKE UNIVERSITY · PI KRAUS, VIRGINIA B. · 2002 to 2006
$1.7M
NIAMS NIH HHS P01 AR050245NIAMS NIH HHS R01 AR048769NIAMS NIH HHS R01 AR052873NIAMS NIH HHS R01AR48769NIA NIH HHS P30 AG028716
6 · The paper itself

Abstract

objectiveTo establish whether there is an association between TSG-6 activity and osteoarthritis progression.

designTSG-6 activity was determined in 132 synovial fluids from patients with OA of the knee, using a novel quantitative TSG-6 activity assay. The association between TSG-6 activities at baseline and four distinct disease progression states, determined at 3-year follow-up, was analyzed using logistic regression.

resultsThere was a statistically significant relationship between TSG-6 activity at baseline and all OA progression states over a 3-year period. Patient knees with TSG-6 activities in the top tenth percentile, compared to the median activity, had an odds ratio (OR) of at least 7.86 (confidence interval (CI) [3.2, 20.5]) for total knee arthroplasty (TKA) within 3 years, and of at least 5.20 (CI [1.8, 13.9]) after adjustment for confounding factors. Receiver operating characteristic (ROC) analysis for knee arthroplasty yielded a cut-off point of 13.3 TSG-6 activity units/ml with the following parameters: area under the curve 0.90 (CI [0.804, 0.996]), sensitivity 0.91 (CI [0.59, 0.99]), specificity 0.82 (CI [0.74, 0.88]) and a negative predictive value (NPV) of 0.99 (CI [0.934, 0.994]).

conclusionThe TSG-6 activity is a promising independent biomarker for OA progression. Given the high NPV, this assay may be particularly suitable for identifying patients at low risk of rapid disease progression and to assist in the timing of arthroplasty.

Indexed as

AgedArthroplasty, Replacement, KneeBiomarkersCell Adhesion MoleculesDisease ProgressionFemaleFollow-Up StudiesHumansLogistic ModelsMaleMiddle AgedOsteoarthritis, KneePrognosisSeverity of Illness IndexSynovial FluidBiomarkersCell Adhesion MoleculesTNFAIP6 protein, humanBiomarkerLogistic regressionOsteoarthritis progressionROC curveTSG-6 activity

Identifiers

PMID24333293
PMCPMC3939799
OpenAlexW2149679683

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.